BBT002 is named as a drug or biological intervention in 3 clinical trials in our China and USA trial registers, 3 of which are recruiting. The lead sponsor is Bambusa Therapeutics. Registered phases: Phase 1 and Phase 1/2. Conditions studied include Chronic Obstructive Pulmonary Disease; Chronic Rhinosinusitis With Nasal Polyps (CRSwNP); Chronic Obstructive Pulmonary Disease (COPD).
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07436949 | A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma (ClinicalTrials.gov ↗) Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) |
Phase 1/2 | Recruiting |
| NCT06944925 | A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) (ClinicalTrials.gov ↗) Chronic Obstructive Pulmonary Disease |
Phase 1 | Recruiting |
| NCT07288554 | A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD) (ClinicalTrials.gov ↗) Chronic Obstructive Pulmonary Disease (COPD) |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Chronic Obstructive Pulmonary Disease | 1 |
| Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 1 |
| Chronic Obstructive Pulmonary Disease (COPD) | 1 |
| Lead sponsor | Trials |
|---|---|
| Bambusa Therapeutics | 3 |
| Register | BBT002 trials |
|---|---|
| Clinical trials in China | 2 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how BBT002 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists BBT002 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.